Press release
Opioid Dependence Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | AstraZeneca, Orexo, Aphios Pharma, DemeRx IB, Inc., Alar Pharmaceuticals, Opiant Pharmaceuticals, Titan Pharmaceuticals,
"Opioid Dependence Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Opioid Dependence Market.
The Opioid Dependence Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Opioid Dependence Pipeline Report: https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Opioid Dependence treatment therapies with a considerable amount of success over the years.
• Opioid Dependence companies working in the treatment market are Gilgamesh Pharmaceuticals, Foresee Pharmaceuticals, Sen Jam Pharmaceutical, AstraZeneca, Lyndra Therapeutics, Indivior Inc., Jazz Pharmaceuticals, Orexo AB, Aphios, DemeRx IB, Inc., and others, are developing therapies for the Opioid Dependence treatment
• Emerging Opioid Dependence therapies in the different phases of clinical trials are- GM-300X, FP 004, SJP 006, AZD4041, LYN-014, INDV-2000, Cnnabidiol, OX 124, APH-1501, DMX-1002, Noribogaine, and others are expected to have a significant impact on the Opioid Dependence market in the coming years.
• In August 2022, Indivior Inc. has commenced a trial named "A Phase I Double-Blind, Placebo-Controlled Randomized Study" to evaluate repeated doses of INDV-2000 (C4X_3256) over a period of up to 28 days in healthy volunteers. Additionally, an open-label study of INDV-2000 for a duration of up to 11 days will be conducted in individuals seeking treatment for Opioid Use Disorder.
Opioid Dependence Overview
Up to two million individuals in the United States suffer from opioid dependence, a chronic, relapsing medical condition that affects millions of others worldwide. Premature death and expensive emergency room and social service utilization are caused by untreated or inadequately managed opioid dependency.
Get a Free Sample PDF Report to know more about Opioid Dependence Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Emerging Opioid Dependence Drugs Under Different Phases of Clinical Development Include:
• GM-300X: Gilgamesh Pharmaceuticals
• FP 004: Foresee Pharmaceuticals
• SJP 006: Sen Jam Pharmaceutical
• AZD4041: AstraZeneca
• LYN-014: Lyndra Therapeutics
• INDV-2000: Indivior Inc.
• Cnnabidiol: Jazz Pharmaceuticals
• OX 124: Orexo AB
Opioid Dependence Route of Administration
Opioid Dependence pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical
Opioid Dependence Molecule Type
Opioid Dependence Products have been categorized under various Molecule types, such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy
Opioid Dependence Pipeline Therapeutics Assessment
• Opioid Dependence Assessment by Product Type
• Opioid Dependence By Stage and Product Type
• Opioid Dependence Assessment by Route of Administration
• Opioid Dependence By Stage and Route of Administration
• Opioid Dependence Assessment by Molecule Type
• Opioid Dependence by Stage and Molecule Type
DelveInsight's Opioid Dependence Report covers around 40+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Opioid Dependence product details are provided in the report. Download the Opioid Dependence pipeline report to learn more about the emerging Opioid Dependence therapies at:
https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key companies in the Opioid Dependence Therapeutics Market include:
Key companies developing therapies for Opioid Dependence are - Orexo, Aphios Pharma, DemeRx IB, Inc., Alar Pharmaceuticals, Opiant Pharmaceuticals, Titan Pharmaceuticals, Lannett Company, BioDelivery Sciences, Amneal Pharmaceuticals, BioXcel Therapeutics, Lyndra Therapeutics, Trevena, Aptinyx, Indivior, Cerevel Therapeutics, BioCorRx, Delpor, AstraZeneca, Gilgamesh Pharmaceuticals, and others.
Opioid Dependence Pipeline Analysis:
The Opioid Dependence pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Opioid Dependence with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Opioid Dependence Treatment.
• Opioid Dependence key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Opioid Dependence Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Opioid Dependence market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Opioid Dependence drugs and therapies-
https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Opioid Dependence Pipeline Market Drivers
• Rising number of incidences of Opioid Abuse, increased R&D Activities are some of the important factors that are fueling the Opioid Dependence Market.
Opioid Dependence Pipeline Market Barriers
• However, side effects associated with the treatment, lack of sufficient number of Opioid treatment programs and other factors are creating obstacles in the Opioid Dependence Market growth.
Scope of Opioid Dependence Pipeline Drug Insight
• Coverage: Global
• Key Opioid Dependence Companies: Gilgamesh Pharmaceuticals, Foresee Pharmaceuticals, Sen Jam Pharmaceutical, AstraZeneca, Lyndra Therapeutics, Indivior Inc., Jazz Pharmaceuticals, Orexo AB, Aphios, DemeRx IB, Inc., and others
• Key Opioid Dependence Therapies: GM-300X, FP 004, SJP 006, AZD4041, LYN-014, INDV-2000, Cnnabidiol, OX 124, APH-1501, DMX-1002, Noribogaine, and others
• Opioid Dependence Therapeutic Assessment: Opioid Dependence current marketed and Opioid Dependence emerging therapies
• Opioid Dependence Market Dynamics: Opioid Dependence market drivers and Opioid Dependence market barriers
Request for Sample PDF Report for Opioid Dependence Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Opioid Dependence Report Introduction
2. Opioid Dependence Executive Summary
3. Opioid Dependence Overview
4. Opioid Dependence- Analytical Perspective In-depth Commercial Assessment
5. Opioid Dependence Pipeline Therapeutics
6. Opioid Dependence Late Stage Products (Phase II/III)
7. Opioid Dependence Mid Stage Products (Phase II)
8. Opioid Dependence Early Stage Products (Phase I)
9. Opioid Dependence Preclinical Stage Products
10. Opioid Dependence Therapeutics Assessment
11. Opioid Dependence Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Opioid Dependence Key Companies
14. Opioid Dependence Key Products
15. Opioid Dependence Unmet Needs
16 . Opioid Dependence Market Drivers and Barriers
17. Opioid Dependence Future Perspectives and Conclusion
18. Opioid Dependence Analyst Views
19. Appendix
20. About DelveInsight
Related Reports:
Opioid Dependence Market https://www.delveinsight.com/report-store/opioid-dependence-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Opioid Dependence Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Opioid Dependence Epidemiology https://www.delveinsight.com/report-store/opioid-dependence-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Opioid Dependence Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.
Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.
Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.
Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.
Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+91-9650213330
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Opioid Dependence Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | AstraZeneca, Orexo, Aphios Pharma, DemeRx IB, Inc., Alar Pharmaceuticals, Opiant Pharmaceuticals, Titan Pharmaceuticals, here
News-ID: 3328174 • Views: …
More Releases from DelveInsight Business Research
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR…
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing prevalence of spinal disorders, especially among the aging population, has substantially driven the demand for corrective surgical procedures. At the same time, the rise in sports-related and trauma-induced spinal injuries is boosting the need for advanced implantable solutions. Additionally, there is a growing preference for non-fusion and motion-preserving devices that maintain spinal mobility and improve patient outcomes, particularly among younger and more active individuals.…
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing global incidence of cancer is boosting the demand for effective treatment options such as tumor ablation. Minimally invasive procedures are becoming more popular due to their shorter recovery periods, reduced risks, and cost-effectiveness compared to conventional surgery. At the same time, technological advancements in tumor ablation devices-such as improvements in radiofrequency, microwave, and cryoablation technologies-have enhanced precision, safety, and effectiveness, making these procedures increasingly…
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts.
DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides…
More Releases for Opioid
Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Opioid-Induced Constipation Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for treatment of opioid-induced constipation has seen a substantial growth recently. It is expected to escalate from a solid $1.78 billion in 2024 to an impressive $1.9 billion in 2025, exhibiting…
Growing Number Of Opioid Addiction Cases: Strategic Insights Driving Opioid Use …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Opioid Use Disorder (OUD) Market Size By 2025?
The market size for opioid use disorder (OUD) has experienced a quick expansion in the past few years. The growth is projected to rise from $3.96 billion in 2024 to $4.39 billion in 2025, boasting a compound…
Key Influencer in the Opioid-Induced Constipation Treatment Market 2025: Rising …
What combination of drivers is leading to accelerated growth in the opioid-induced constipation treatment market?
The rise in opioid administration for cancer and non-cancer pain is expected to drive the growth of the opioid-induced constipation (OIC) treatment market. Opioids are commonly used for managing moderate to severe pain, but they can cause constipation. OIC treatments are vital for improving the quality of life for patients on opioids, allowing them to maintain…
Top Factor Driving Opioid Use Disorder (OUD) Market Growth in 2025: Growing Numb …
How Are the key drivers contributing to the expansion of the opioid use disorder (oud) market?
The rise in instances of opioid dependency is set to fuel the expansion of the opioid use disorder (OUD) market. Opioid dependency defines a health concern marked by habitual and uncontrolled opioid consumption which negatively impacts health. These opioids can generate feelings of bliss and relief from pain, but continued usage often results in tolerance…
What's Driving the Opioid-Induced Constipation Treatment Market 2025-2034: Risin …
What Are the Projections for the Size and Growth Rate of the Opioid-Induced Constipation Treatment Market?
The market size for treatments of constipation caused by opioids has seen robust growth lately. The forecasted growth indicates an increase from $1.78 billion in 2024 to $1.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%. This past growth is associated with a growing elderly population, individualized treatments for OIC, the…
MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana.
Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622
Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal…
